Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.
Karl A, Buchner A, Tympner C, Kirchner T, Ganswindt U, Belka C, Ganzer R, Burger M, Eder F, Hofstädter F, Schilling D, Sievert K, Stenzl A, Scharpf M, Fend F, Vom Dorp F, Rübben H, Schmid K, Porres-Knoblauch D, Heidenreich A, Hangarter B, Knüchel-Clarke R, Rogenhofer M, Wullich B, Hartmann A, Comploj E, Pycha A, Hanspeter E, Pehrke D, Sauter G, Graefen M, Stief C, Haese A. Karl A, et al. Among authors: hanspeter e. World J Urol. 2015 Jul;33(7):973-9. doi: 10.1007/s00345-015-1510-y. Epub 2015 Feb 15. World J Urol. 2015. PMID: 25682109
Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin - A multicenter study.
Karl A, Buchner A, Tympner C, Kirchner T, Ganswindt U, Belka C, Ganzer R, Wieland W, Eder F, Hofstädter F, Schilling D, Sievert KD, Stenzl A, Scharpf M, Fend F, Vom Dorp F, Rübben H, Schmid KW, Porres-Knoblauch D, Heidenreich A, Hangarter B, Knüchel-Clarke R, Rogenhofer M, Wullich B, Hartmann A, Comploj E, Pycha A, Hanspeter E, Pehrke D, Sauter G, Graefen M, Gratzke C, Stief C, Wiegel T, Haese A. Karl A, et al. Among authors: hanspeter e. Radiother Oncol. 2015 Jul;116(1):119-24. doi: 10.1016/j.radonc.2015.06.021. Epub 2015 Jun 29. Radiother Oncol. 2015. PMID: 26138059
Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.
Karl A, Buchner A, Tympner C, Kirchner T, Ganswindt U, Belka C, Ganzer R, Burger M, Eder F, Hofstädter F, Schilling D, Sievert K, Stenzl A, Scharpf M, Fend F, Dorp FV, Rübben H, Schmid K, Porres-Knoblauch D, Heidenreich A, Hangarter B, Knuchel-Clarke R, Rogenhofer M, Wullich B, Hartmann A, Comploj E, Pycha A, Hanspeter E, Pehrke D, Sauter G, Graefen M, Stief C, Haese A. Karl A, et al. Among authors: hanspeter e. World J Urol. 2020 Jun;38(6):1587-1588. doi: 10.1007/s00345-020-03136-9. World J Urol. 2020. PMID: 32076820
Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy.
Lodde M, Mayr R, Martini T, Comploj E, Palermo S, Trenti E, Hanspeter E, Fritsche HM, Mian C, Pycha A. Lodde M, et al. Among authors: hanspeter e. World J Urol. 2012 Dec;30(6):841-6. doi: 10.1007/s00345-012-0975-1. Epub 2012 Nov 10. World J Urol. 2012. PMID: 23143733
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment.
Fontugne J, Lee D, Cantaloni C, Barbieri CE, Caffo O, Hanspeter E, Mazzoleni G, Dalla Palma P, Rubin MA, Fellin G, Mosquera JM, Barbareschi M, Demichelis F. Fontugne J, et al. Among authors: hanspeter e. Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):594-600. doi: 10.1158/1055-9965.EPI-13-1180. Epub 2014 Feb 10. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 24515272 Free PMC article.
34 results